-
公开(公告)号:US11851670B2
公开(公告)日:2023-12-26
申请号:US16438424
申请日:2019-06-11
Applicant: Whitehead Institute for Biomedical Research
Inventor: Rudolf Jaenisch , Bryce Woodbury Carey , Yaqub Hanna
IPC: C12N5/074 , C12N15/86 , G01N33/50 , A01K67/027 , C07K14/47 , C12N15/85 , C12N5/0735 , C12N15/79
CPC classification number: C12N15/86 , A01K67/0271 , C07K14/4705 , C12N5/0696 , G01N33/5008 , C12N5/0606 , C12N15/79 , C12N15/85 , C12N2501/60 , C12N2501/602 , C12N2501/603 , C12N2501/604 , C12N2501/605 , C12N2501/606 , C12N2501/608 , C12N2506/11 , C12N2506/115 , C12N2510/00 , C12N2740/15041 , C12N2740/15043 , C12N2740/16043 , C12N2799/027 , C12N2800/108 , C12N2840/203
Abstract: The disclosure relates to a method of reprogramming one or more somatic cells, e.g., partially differentiated or fully/terminally differentiated somatic cells, to a less differentiated state, e.g., a pluripotent or multipotent state. In further embodiments the invention also relates to reprogrammed somatic cells produced by methods of the invention, to chimeric animals comprising reprogrammed somatic cells of the invention, to uses of said cells, and to methods for identifying agents useful for reprogramming somatic cells.
-
公开(公告)号:US20230085214A1
公开(公告)日:2023-03-16
申请号:US17869611
申请日:2022-07-20
Inventor: Hua Wang , Andrew Salim Khalil , David J. Mooney , Rudolf Jaenisch
Abstract: Disclosed herein are compositions and methods for labeling cells using click chemistry reagents. The compositions and methods disclosed herein provide a specific and efficient means of localizing desired agents to a variety of cell types in vivo and in vitro. The compositions and methods disclosed herein can be used to deliver a variety of desired agents to a cell or population of cells to direct cell fate and/or cell differentiation.
-
公开(公告)号:US11434476B2
公开(公告)日:2022-09-06
申请号:US16326700
申请日:2017-08-18
Applicant: Whitehead Institute for Biomedical Research
Inventor: Rudolf Jaenisch , X Shawn Liu , Hao Wu
IPC: C12N9/22 , A61K35/30 , A61K35/33 , C12N9/10 , C12N15/11 , C12N15/86 , C12N15/90 , A61P3/10 , A61P9/00 , A61P9/10 , A61P9/12 , A61P11/00 , A61P25/00 , A61P25/16 , A61P25/28 , A61P35/00 , A61P37/06 , A61K38/46 , C12N15/00 , C12N15/113 , A61K31/7088
Abstract: The invention relates to methods of modifying DNA methylation by contacting a catalytically inactive site specific nuclease fused to an effector domain having methylation or demethylation activity and one or more guide sequences.
-
公开(公告)号:US20210230538A1
公开(公告)日:2021-07-29
申请号:US17071627
申请日:2020-10-15
Inventor: Thorold W. Theunissen , Nathanael S. Gray , Rudolf Jaenisch
IPC: C12N5/0735 , C12N5/074
Abstract: The present disclosure provides compounds of any one of Formulae (A) to (L). The present disclosure also provides compositions, uses, and methods that include or involve a compound described herein, a serine/threonine-protein kinase B-Raf (BRAF) inhibitor, an epidermal growth factor receptor (EGFR) inhibitor, a vascular endothelial growth factor 1 (VEGFR1) inhibitor, a fibroblast growth factor receptor 1 (FGFR1) inhibitor, or a combination thereof. The compounds, compositions, uses, and methods are useful in changing the pluripotency state of a vertebrate cell to a more nave state.
-
公开(公告)号:US20200239855A1
公开(公告)日:2020-07-30
申请号:US16665821
申请日:2019-10-28
Applicant: Whitehead Institute for Biomedical Research
Inventor: Rudolf Jaenisch , Konrad Hochedlinger
IPC: C12N5/074 , C12N15/85 , C07K14/47 , C12N15/877 , A01K67/027
Abstract: The invention provides methods for reprogramming somatic cells to generate multipotent or pluripotent cells. Such methods are useful for a variety of purposes, including treating or preventing a medical condition in an individual. The invention further provides methods for identifying an agent that reprograms somatic cells to a less differentiated state.
-
公开(公告)号:US20190241874A1
公开(公告)日:2019-08-08
申请号:US16147003
申请日:2018-09-28
Applicant: Whitehead Institute for Biomedical Research
Inventor: Rudolf Jaenisch , Yaqub Hanna , Marius Wernig , Christopher J. Lengner , Alexander Meissner , Oliver Tobias Brambrink , G. Grant Welstead , Ruth Foreman
CPC classification number: C12N5/0696 , A01K67/0273 , A01K67/0275 , A01K2217/05 , A01K2227/105 , C07K14/4702 , C12N15/8509 , C12N15/8775 , C12N2501/602 , C12N2501/603 , C12N2501/604 , C12N2501/605 , C12N2501/606 , C12N2506/11 , C12N2506/13 , C12N2800/30 , C12N2830/003 , C12N2830/006 , G01N33/5023 , G01N2333/91011
Abstract: The disclosure relates to a method of reprogramming one or more somatic cells, e.g., partially differentiated or fully/terminally differentiated somatic cells, to a less differentiated state, e.g., a pluripotent or multipotent state. In further embodiments the invention also relates to reprogrammed somatic cells produced by methods of the invention, to uses of said cells, and to methods for identifying agents useful for reprogramming somatic cells.
-
公开(公告)号:US20190078057A1
公开(公告)日:2019-03-14
申请号:US16030815
申请日:2018-07-09
Applicant: Whitehead Institute for Biomedical Research
Inventor: Rudolf Jaenisch , Konrad Hochedlinger
IPC: C12N5/074 , C12N15/85 , A01K67/027 , C07K14/47 , C12N15/877
CPC classification number: C12N5/0696 , A01K67/0273 , A01K67/0275 , A01K2217/05 , A01K2227/105 , C07K14/4702 , C12N15/85 , C12N15/8509 , C12N15/8775 , C12N2501/602 , C12N2501/603 , C12N2501/605 , C12N2506/1307 , C12N2510/00 , C12N2830/003 , C12N2830/006
Abstract: The invention provides methods for reprogramming somatic cells to generate multipotent or pluripotent cells. Such methods are useful for a variety of purposes, including treating or preventing a medical condition in an individual. The invention further provides methods for identifying an agent that reprograms somatic cells to a less differentiated state.
-
公开(公告)号:US20170240865A1
公开(公告)日:2017-08-24
申请号:US15588062
申请日:2017-05-05
Applicant: Whitehead Institute for Biomedical Research
Inventor: Rudolf Jaenisch , Konrad Hochedlinger
IPC: C12N5/074
CPC classification number: C12N5/0696 , A01K67/0273 , A01K67/0275 , A01K2217/05 , A01K2227/105 , C07K14/4702 , C12N15/85 , C12N15/8509 , C12N15/8775 , C12N2501/602 , C12N2501/603 , C12N2501/605 , C12N2506/1307 , C12N2510/00 , C12N2830/003 , C12N2830/006
Abstract: The invention provides methods for reprogramming somatic cells to generate multipotent or pluripotent cells. Such methods are useful for a variety of purposes, including treating or preventing a medical condition in an individual. The invention further provides methods for identifying an agent that reprograms somatic cells to a less differentiated state.
-
公开(公告)号:US09169490B2
公开(公告)日:2015-10-27
申请号:US13646430
申请日:2012-10-05
Applicant: Whitehead Institute for Biomedical Research
Inventor: Rudolf Jaenisch , Konrad Hochedlinger
IPC: C12N15/85 , C12N5/074 , A01K67/027 , C07K14/47 , C12N15/877
CPC classification number: C12N5/0696 , A01K67/0273 , A01K67/0275 , A01K2217/05 , A01K2227/105 , C07K14/4702 , C12N15/85 , C12N15/8509 , C12N15/8775 , C12N2501/602 , C12N2501/603 , C12N2501/605 , C12N2506/1307 , C12N2510/00 , C12N2830/003 , C12N2830/006
Abstract: The invention provides methods for reprogramming somatic cells to generate multipotent or pluripotent cells. Such methods are useful for a variety of purposes, including treating or preventing a medical condition in an individual. The invention further provides methods for identifying an agent that reprograms somatic cells to a less differentiated state.
Abstract translation: 本发明提供了重编程体细胞产生多潜能或多潜能细胞的方法。 这些方法可用于各种目的,包括治疗或预防个体的医疗状况。 本发明进一步提供了用于鉴定将体细胞重新编程为较差分化状态的药剂的方法。
-
公开(公告)号:US20130109089A1
公开(公告)日:2013-05-02
申请号:US13646411
申请日:2012-10-05
Applicant: Whitehead Institute for Biomedical Research
Inventor: Rudolf Jaenisch , Konrad Hochedlinger
IPC: C12N15/85
CPC classification number: C12N5/0696 , A01K67/0273 , A01K67/0275 , A01K2217/05 , A01K2227/105 , C07K14/4702 , C12N15/85 , C12N15/8509 , C12N15/8775 , C12N2501/602 , C12N2501/603 , C12N2501/605 , C12N2506/1307 , C12N2510/00 , C12N2830/003 , C12N2830/006
Abstract: The invention provides methods for reprogramming somatic cells to generate multipotent or pluripotent cells. Such methods are useful for a variety of purposes, including treating or preventing a medical condition in an individual. The invention further provides methods for identifying an agent that reprograms somatic cells to a less differentiated state.
-
-
-
-
-
-
-
-
-